Future therapeutic perspectives for tension-type headache

Marc E Lenaerts

doi:10.1007/s11916-007-0234-0

Future therapeutic perspectives for tension-type headache

Research output: Contribution to journal › Article

Abstract

The therapy for tension-type headache remains insufficient, and recent advances have been scarce. Although tricyclic antidepressants are at the forefront of treatment advances, upcoming agents tentatively modifying central sensitization are promising. Botulinum toxin failed to meet expectations. This article reviews current treatments, emphasizing newer approaches. Much remains to be achieved.

Original language	English (US)
Pages (from-to)	461-464
Number of pages	4
Journal	Current Pain and Headache Reports
Volume	11
Issue number	6
DOIs	https://doi.org/10.1007/s11916-007-0234-0
State	Published - Dec 2007
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Medicine(all)

Cite this

Lenaerts, M. E. (2007). Future therapeutic perspectives for tension-type headache. Current Pain and Headache Reports, 11(6), 461-464. https://doi.org/10.1007/s11916-007-0234-0

@article{6c04feb9d8d448c58e14d65e9a1e9074,

title = "Future therapeutic perspectives for tension-type headache",

abstract = "The therapy for tension-type headache remains insufficient, and recent advances have been scarce. Although tricyclic antidepressants are at the forefront of treatment advances, upcoming agents tentatively modifying central sensitization are promising. Botulinum toxin failed to meet expectations. This article reviews current treatments, emphasizing newer approaches. Much remains to be achieved.",

author = "Lenaerts, {Marc E}",

year = "2007",

month = dec

doi = "10.1007/s11916-007-0234-0",

language = "English (US)",

volume = "11",

pages = "461--464",

journal = "Current Pain and Headache Reports",

issn = "1531-3433",

publisher = "Current Science, Inc.",

number = "6",

}

TY - JOUR

T1 - Future therapeutic perspectives for tension-type headache

AU - Lenaerts, Marc E

PY - 2007/12

Y1 - 2007/12

N2 - The therapy for tension-type headache remains insufficient, and recent advances have been scarce. Although tricyclic antidepressants are at the forefront of treatment advances, upcoming agents tentatively modifying central sensitization are promising. Botulinum toxin failed to meet expectations. This article reviews current treatments, emphasizing newer approaches. Much remains to be achieved.

AB - The therapy for tension-type headache remains insufficient, and recent advances have been scarce. Although tricyclic antidepressants are at the forefront of treatment advances, upcoming agents tentatively modifying central sensitization are promising. Botulinum toxin failed to meet expectations. This article reviews current treatments, emphasizing newer approaches. Much remains to be achieved.

UR - http://www.scopus.com/inward/record.url?scp=36849034338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849034338&partnerID=8YFLogxK

U2 - 10.1007/s11916-007-0234-0

DO - 10.1007/s11916-007-0234-0

M3 - Article

C2 - 18173982

AN - SCOPUS:36849034338

VL - 11

SP - 461

EP - 464

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 6

ER -

Access to Document

10.1007/s11916-007-0234-0